Pharnext

Lafarge Platres

Etex Building Performance International Sas

Galderma S.a.

Galderma Holding Sa

Siniat

Emmanuel Vial

Ilya Chumakov

Daniel Cohen

Serguei Nabirochkin

Hye-Mi Lee

Mickael Guedj

Roger Arese

André Jomard

Paul Jallon

Feriel Hacini-Rachinel

Pauline Lopez

Jean-Louis Laurent

Lionel Zbinden

Loic Martin

Frederic Peronnet

Gennaro Magliulo

Crescenzo Petrone

Mickaël Guedj

Jean Jacovella

Nicolas Costa

Pierre Peyron

Julien Soulhat

Yong-Sam Park

Andrew Watkins

Mark Shaddick

Cyrille Demanet

Julian Tizianel

Stéphan Zerbib

Gaël Maille

Emiie Savanier

Mélina Jean

Jimmy Chaouche

Frédéric Ple

Bastien Rouanet

The present invention relates to a pharmaceutical composition comprising a compound of the avermectin family, preferably ivermectin, in a pharmaceutically acceptable carrier, for use in the treatment and/or prevention of hand eczema.

Compositions comprising a compound of the avermectin family for the treatment and/or prevention of hand eczema

The present invention relates to compositions and methods for the treatment of neurological disorders related to glutamate excitotoxicity and Amyloid &#x3b2; toxicity. More specifically, the present invention relates to novel combinatorial therapies of Multiple Sclerosis, Alzheimer's disease, Alzheimer's disease related disorders, Amyotrophic Lateral Sclerosis, Parkinson's disease, Huntington's disease, neuropathic pain, alcoholic neuropathy, alcoholism or alcohol withdrawal, or spinal cord injury.

Compositions for treating neurological disorders

A method of treating and/or preventing atopic dermatitis is described. The method includes use of a compound of the avermectin family, possibly ivermectin, or a compound of the milbemycin family in a pharmaceutically acceptable carrier.

Compound of the avermectin family or of the milbemycin family for the treatment and/or prevention of atopic dermatitis

A seismic protective structure () for forming part of a board partition () and for limiting damage to the board partition () when a given level of seismic stress is appearing is described. The seismic protective structure () comprises at least one board () and support elements () for positioning the board adjacent a neighboring wall and linking the board to the remainder of the board partition wall. The seismic protective structure () is adapted for, when a given level of seismic stress is appearing, intentionally causing damage of the at least one board () thereby releasing pressure from the remainder of the board partition ().

Protective structure for board partitions

The present invention relates to compositions and methods for the treatment of neurological disorders related to glutamate excitotoxicity and Amyloid &#x3b2; toxicity. More specifically, the present invention relates to novel combinatorial therapies of multiple sclerosis, Alzheimer's disease, Alzheimer's disease-related disorders, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease, neuropathic pain, alcoholic neuropathy, alcoholism or alcohol withdrawal, or spinal cord injury.

Composition comprising torasemide and baclofen for treating neurological disorders

Seismic damage reducing system for partitions. A seismic protective structure () for forming part of a board partition () and for limiting damage to the board partition () when a given level of seismic stress is appearing, is described. The seismic protective structure () comprising a breaking mechanism () introduced near an upper corner and/or lower corner of board partition (), wherein the breaking mechanism () is adapted for, when a given level of seismic stress is appearing, intentionally causing damage of the board partition () thereby releasing stress from the remainder of the board partition ().

Seismic damage reducing system for partitions

The present invention relates to new compositions and methods for protecting neuronal cells from ischemic or hypoxic events. More precisely, this invention provides new combinatorial therapies that efficiently protect neuronal cells from ischemia or hypoxia.

Treatment of cerebral ischemia

The present invention relates to combinations and methods for the treatment of neurological disorders related to glutamate excitotoxicity and Amyloid &#x3b2; toxicity. More specifically, the present invention relates to novel combinatorial therapies of Alzheimer's disease, Alzheimer's disease related disorders, amyotrophic lateral sclerosis, multiple sclerosis, Parkinson's disease, Huntington's disease, neuropathic pain, alcoholic neuropathy, alcoholism or alcohol withdrawal, or spinal cord injury, based on baclofen and acamprosate combination.

Baclofen and acamprosate based therapy of neurological disorders

The present invention relates to combinations and methods for the treatment of neurological disorders related to glutamate excitotoxicity and Amyloid &#x3b2; toxicity. More specifically, the present invention relates to novel combinatorial therapies of Multiple Sclerosis, Alzheimer's disease, Alzheimer's disease related disorder, Amyotrophic Lateral Sclerosis, Parkinson's disease, Huntington's disease, neuropathic pain, alcoholic neuropathy, alcoholism or alcohol withdrawal, or spinal cord injury, based on Baclofen and Acamprosate combination.

The subject of the invention is a novel plasterboard and its manufacturing processes. The novel board comprises, on one side, two first parallel feathered edges and, on the other side, two other, second, parallel feathered edges that are perpendicular to the first ones; or, on one side, two first parallel feathered edges and, either on the same side or on the other side, two second parallel feathered edges that are perpendicular to the first ones, the said other parallel feathered edges having a width of between 100 and 200 mm; or, on one side, two first parallel feathered edges and, either on the same side or on the other side, two second parallel feathered edges that are perpendicular to the first ones, the said second parallel feathered edges having a width such that the ratio of the width of the said second parallel feathered edges to the width of the said first parallel feathered edges is between 1.5 and 5.

Production line for hydraulic binder-based, tapered-edge boards

Production method for hydraulic binder-based, tapered-edge boards

Growing community of inventors

Paris, France

Emmanuel Vial